MedPath
NMPA Approval

Hydrotalcite Suspension

国药准字H20253652

March 18, 2025

Drug Information

铝碳酸镁混悬液

口服混悬剂

10ml:1g

化学药品

March 18, 2025

Company Information

Applicant Company

太康县产业集聚区

Manufacturing Company

太康县产业集聚区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

铝碳酸镁混悬液 - NMPA 批准文号 | MedPath